Anzeige
Mehr »
Mittwoch, 23.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CGS | ISIN: US4618741098 | Ticker-Symbol:
NASDAQ
22.07.25 | 17:03
9,200 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXOZYMES INC Chart 1 Jahr
5-Tage-Chart
EXOZYMES INC 5-Tage-Chart

Aktuelle News zur EXOZYMES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DieXoZymes meldet Durchbruch bei Bioproduktion von NCT3
DieXoZymes achieves breakthrough in NCT biomanufacturing process2
DieXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months313N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial...
► Artikel lesen
07.07.Hedge Fund and Insider Trading News: Bill Ackman, Michael Platt, Scott Bessent, Point72 Asset Management, Berkshire Hathaway, Lakehouse Capital, Exozymes Inc (EXOZ), and More38
26.06.eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing288MONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines...
► Artikel lesen
EXOZYMES Aktie jetzt für 0€ handeln
20.06.EXOZYMES INC. - 8-K, Current Report1
16.05.eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast400MONROVIA, CALIFORNIA / ACCESS Newswire / May 16, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals...
► Artikel lesen
13.05.eXoZymes reports Q1 results2
12.05.eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today280Management to host earnings call at 5:00PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that...
► Artikel lesen
12.05.EXOZYMES INC. - 10-Q, Quarterly Report3
07.05.eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST329MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines,...
► Artikel lesen
06.05.eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health275N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier...
► Artikel lesen
25.04.EXOZYMES INC. - S-8, Securities to be offered to employees in employee benefit plans2
21.04.eXoZymes Inc.: Bringing clarity and precision to the cell-free space by introducing exozymes1
12.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presiden867New to The Street debuts its inaugural restaurant segment featuring BlackBarn with owner and chef John Doherty NEW YORK CITY, NY / ACCESS Newswire / April 12, 2025 / New to The Street, a leading financial...
► Artikel lesen
11.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie's Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President T552BlackBarn Restaurant NYC on 26th street The premiere restaurant segment with Owner and Head Chef John Doherty NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / New to The Street, a leading...
► Artikel lesen
11.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presiden429New Segment "Market Bites" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / New to The Street...
► Artikel lesen
10.04.eXoZymes Inc.: BioClick - an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant2
02.04.EXOZYMES INC. - 8-K, Current Report1
02.04.eXoZymes appoints new chief commercial officer1
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1